Stay updated on Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.

Latest updates to the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page
- Check5 days agoChange DetectedA sitewide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision advances from v3.7.1 to v3.7.2. The study record remains unavailable behind a 403 error.SummaryDifference1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe site's displayed revision number changed from v3.7.0 to v3.7.1 on the error page.SummaryDifference0.2%

- Check26 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden page, replacing the study details with an access-restriction message. The page still shows navigation elements such as a Home button and the site footer, indicating a restricted view rather than the study information.SummaryDifference0.5%

- Check33 days agoChange DetectedThe study page now shows a 403 Forbidden error instead of the study details. This suggests restricted access or a server/configuration issue rather than a content update.SummaryDifference18%

- Check40 days agoChange DetectedThe page now displays revision v3.7.0, replacing the previous v3.6.6 label. This reflects an update to the study page's revision metadata rather than substantive content changes.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, reflecting a new version of the page. This change is confined to metadata and does not alter the displayed content or behavior.SummaryDifference0.1%

Stay in the know with updates to Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.